ARTICLE | Clinical News
ReN1869: Began Phase II testing
January 2, 2001 8:00 AM UTC
ReNeuron Ltd. (LSE:REN), London, U.K. Product: ReN1869 Business: Neurological Therapeutic category: Neurotransmission Target: C-fibers Description: Neurin that acts on C-fibers that transmit pain and...